Imugene Limited

Imugene Limitedverified

IUGNF

Price:

$0.2

Market Cap:

$92.36M

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research ...[Read more]

Industry

Biotechnology

IPO Date

2019-07-05

Stock Exchange

OTC

Ticker

IUGNF

The PE Ratio as of December 2025 (TTM) for Imugene Limited (IUGNF) is -0.95

According to Imugene Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.95. This represents a change of -42.27% compared to the average of -1.65 of the last 4 quarters.

Imugene Limited (IUGNF) Historical PE Ratio (quarterly & annually)

How has IUGNF PE Ratio performed in the past?

The mean historical PE Ratio of Imugene Limited over the last ten years is -18.93. The current -0.95 PE Ratio has changed 401.83% with respect to the historical average. Over the past ten years (40 quarters), IUGNF's PE Ratio was at its highest in in the December 2008 quarter at 360.73. The PE Ratio was at its lowest in in the January 2007 quarter at -275.35.

Quarterly (TTM)
Annual

Average

-18.93

Median

-11.76

Minimum

-89.71

Maximum

-1.40

Imugene Limited (IUGNF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Imugene Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 649.07%

Maximum Annual PE Ratio = -1.40

Minimum Annual Increase = -82.68%

Minimum Annual PE Ratio = -89.71

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.40-46.23%
2024-2.60-82.68%
2023-15.04-43.86%
2022-26.79-70.13%
2021-89.71649.07%
2020-11.9873.30%
2019-6.91-64.46%
2018-19.4568.31%
2017-11.55198.57%
2016-3.87-27.00%

Imugene Limited (IUGNF) Average PE Ratio

How has IUGNF PE Ratio performed in the past?

The current PE Ratio of Imugene Limited (IUGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.35

5-year avg

-27.11

10-year avg

-18.93

Imugene Limited (IUGNF) PE Ratio vs. Peers

How is IUGNF’s PE Ratio compared to its peers?

Imugene Limited’s PE Ratio is greater than Alterity Therapeutics Limited (-4.93), greater than Starpharma Holdings Limited (-16.54), greater than Satellos Bioscience Inc. (-1.76), less than Nicox S.A. (-0.68), less than BioStem Technologies, Inc. (2.69), greater than Poolbeg Pharma PLC (-3.30), less than VitaSpring Biomedical Co. Ltd. (162.96), less than H-Source Holdings Ltd. (-0.00), less than Kintor Pharmaceutical Limited (0), greater than Calliditas Therapeutics AB (publ) (-23.95),

Build a custom stock screener for Imugene Limited (IUGNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imugene Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Imugene Limited (IUGNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Imugene Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Imugene Limited's PE Ratio?

How is the PE Ratio calculated for Imugene Limited (IUGNF)?

What is the highest PE Ratio for Imugene Limited (IUGNF)?

What is the 3-year average PE Ratio for Imugene Limited (IUGNF)?

What is the 5-year average PE Ratio for Imugene Limited (IUGNF)?

How does the current PE Ratio for Imugene Limited (IUGNF) compare to its historical average?